THEOREMA
LIVE

Serial Number

99946330

Owner

Theorema Inc.

Attorney

Ben Natter

Filing Date

Jul 17, 2026

Add to watchlist:

No watchlists yet
View on USPTO

THEOREMA Trademark

Serial Number: 99946330

THEOREMA is a trademark filed by Theorema Inc. on July 17, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Theorema Inc.

838 Walker Road, Suite 21-2, City of Dover, County of Kent,
Dover, DE 19904

Entity Type: 03

Trademark Details

Filing Date

July 17, 2026

Registration Date

Not Registered

Goods & Services

Business consulting services in the fields of life sciences, biotechnology, pharmaceuticals, chemistry, materials science, and related scientific disciplines; business development consulting services; business advisory services relating to the acquisition, licensing, commercialization, and management of scientific, pharmaceutical, biotechnology, and technology assets; business evaluation of scientific, pharmaceutical, biotechnology, and technology assets; matching buyers and sellers of scientific, pharmaceutical, biotechnology, and technology assets; business research and analysis relating to licensing opportunities, asset sourcing, asset acquisition, and commercialization strategies; providing business information and business intelligence relating to scientific, pharmaceutical, biotechnology, and technology markets

Software as a service (SaaS) services featuring software that utilizes artificial intelligence for scientific research, literature review, data analysis, hypothesis generation, and research workflow automation; providing temporary use of online non-downloadable software for analyzing scientific and technical data, generating research insights, and supporting research and development activities; scientific research and development services; scientific consulting services in the fields of life sciences, biotechnology, pharmaceuticals, chemistry, materials science, and related scientific disciplines; conducting scientific evaluations, analyses, and assessments relating to target discovery, biomarker discovery, translational research, scientific research prioritization, scientific asset evaluation, patent clearance, intellectual property assessments, exclusivity analyses, regulatory strategy, and submission readiness; technical due diligence services relating to scientific, pharmaceutical, biotechnology, and technology assets; research and development of pharmaceutical, biotechnological, chemical, and materials science technologies, products, compounds, molecules, and intellectual property assets

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 17, 2026 MAFR
NEW APPLICATION ENTERED
Jul 17, 2026 NWAP